Evidence map›Paper›PMID 40323670›Full record

ArticleAIDS education and prevention : official publication of the International Society for AIDS Education2025

The Longitudinal Impact of Psychosocial Syndemic Variables on Adherence to Antiretroviral Therapy Among People With HIV in Brazil, Thailand, and Zambia: An Analysis by HIV Transmission Groups in HPTN 063.

Carlos E Rodríguez-Díaz, Sahar Z Zangeneh, Yumei O Chen, Xu Guo, Kiyomi Tsuyuki, Yusuf Ransome, Ruth K Friedman, Kriengkrai Srithanaviboonchai, Sarah T Roberts, Matthew J Mimiaga and 2 more

Abstract read
In one paragraph

Article in AIDS education and prevention : official publication of the International Society for AIDS Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carlos E Rodríguez-DíazBoston University School of Public Health.
Sahar Z ZangenehRTI International, Durham, North Carolina; School of Public Health, University of Washington.
Yumei O ChenDepartment of Psychology, University of Miami.
Xu GuoStatistical Center for HIV/AIDS Research and Prevention Fred Hutch Cancer Center, Seattle, Washington.
Kiyomi TsuyukiDivision of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego.
Yusuf RansomeSchool of Public Health, Yale University.
Ruth K FriedmanInstituto de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil.
Kriengkrai SrithanaviboonchaiFaculty of Medicine, Chiang Mai University and the Research Institute for Health Sciences, Chiang Mai University, Chang Mai, Thailand.
Sarah T RobertsWomen's Global Health Imperative, RTI International.
Matthew J MimiagaFielding School of Public Health, University of California Los Angeles.
Kenneth H MayerThe Fenway Institute, Fenway Health, Boston, Massachusetts.
Steven A SafrenDepartment of Psychology, University of Miami.

Funding

LOC: HIV Prevention Trials NetworkUM1AI068619 · NIAID · FAMILY HEALTH INTERNATIONAL · PI Sinead Delany-Moretlwe, RAPHAEL J LANDOVITZ · 2011 to 2026
$779.5M
Harvard Medical School Vaccine Clinical Trials UnitUM1AI069412 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Lindsey Robert Baden, Daniel R. Kuritzkes · 2012 to 2026
$57.2M
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit (FioTrials)UM1AI069476 · NIAID · FUNDACAO OSWALDO CRUZ · PI BEATRIZ GRINSZTEJN · 2012 to 2026
$26.3M
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core & MHD-CEP30MH133399 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI Steven A Safren · 2023 to 2026
$8.9M
Partners Healthcare Systems/Harvard Medical School/Boston Medical Center AIDS CTUUM1AI069472 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI KURITZKES, DANIEL R. · 2012 to 2014
$6.0M
NIAID NIH HHS UM1 AI068619NIAID NIH HHS UM1 AI069412NIAID NIH HHS UM1 AI069472NIAID NIH HHS UM1 AI069476NIMH NIH HHS P30 MH133399
6 · The paper itself

Abstract

In the field of HIV prevention and care, most studies of HIV syndemic problems are cross-sectional, few differentiate by HIV transmission groups, and few focus on people living with HIV (PWH). We analyzed one-year longitudinal data of 692 sexually active PWH (heterosexual men [HM], heterosexual women [HW], and men who have sex with men [MSM]) in care from Brazil, Thailand, and Zambia. Syndemic scores (0-3+) included stimulant use, polydrug use, depression, alcohol use, and fear of discrimination. Overall, syndemic scores were associated with lower ART adherence over time, but this differed across sexual transmission categories. For HM and HW, those with 2 or 3+ syndemic problems had lower odds of ART adherence than those with none. However, for MSM, the association between syndemic scores and ART adherence was not significant. While syndemic problems generally predicted suboptimal ART adherence among PWH, the association appears nuanced across subgroups.

Indexed as

Anti-HIV AgentsHIV InfectionsMedication AdherenceSyndemicAdultBrazilCross-Sectional StudiesFemaleHeterosexualityHomosexuality, MaleHumansLongitudinal StudiesMaleMiddle AgedSubstance-Related DisordersThailandAnti-HIV AgentsART adherencelongitudinal logistic regressionsyndemics

Identifiers

PMID40323670
PMCPMC12334064

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.